Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,039

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

McLean, Gordon W., Carragher, Neil O., Avizienyte, Egle, Evans, Jeff, Brunton, Valerie G., Frame, Margaret C.·2005·Nature Reviews Cancer
DOI 10.1038/nrc1647
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc1647

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 116

  1. Carragher, N. O. & Frame, M. C. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 14, 241–249 (2004). · DOI · Paper page
  2. Weiner, T. M., Liu, E. T., Craven, R. J. & Cance, W. G. Expression of focal adhesion kinase gene and invasive cancer. Lancet 342, 1024–1025 (1993). · DOI · Paper page
  3. Owens, L. V. et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res. 55, 2752–2755 (1995).
  4. Owens, L. V. et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3, 100–105 (1996). · DOI
  5. Tremblay, L. et al. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int. J. Cancer 68, 164–171 (1996). · DOI
  6. McCormack, S. J., Brazinski, S. E., Moore, J. L. Jr, Werness, B. A. & Goldstein, D. J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 15, 265–274 (1997). · DOI
  7. Kornberg, L. J. Focal adhesion kinase expression in oral cancers. Head Neck 20, 634–639 (1998). · DOI
  8. Kornberg, L. J. Focal adhesion kinase and its potential involvement in tumour invasion and metastasis. Head Neck 20, 745–752 (1998). · DOI
  9. Judson, P. L., He, X., Cance, W. G. & Van Le, L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86, 1551–1556 (1999). · DOI
  10. Cance, W. G. et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6, 2417–2423 (2000).
  11. Lark, A. L. et al. Overexpression of focal adhesion kinase in primary colourectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9, 215–222 (2003).
  12. Gabriel, B. et al. Focal adhesion kinase interacts with the transcriptional co-activator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res. 24, 921–927 (2004).
  13. Recher, C. et al. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res. 64, 3191–3197 (2004). · DOI
  14. Schlaepfer, D. D., Mitra, S. K. & Ilic, D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 1692, 77–102 (2004). · DOI · Paper page
  15. Sood, A. K. et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am. J. Pathol. 165, 1087–1095 (2004). · DOI
  16. Ayaki, M. et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colourectal adenocarcinomas. Clin. Cancer Res. 7, 3106–3112 (2001).
  17. Agochiya, M. et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18, 5646–5653 (1999). · DOI
  18. Golubovskaya, V., Kaur, A. & Cance, W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor κB and p53 binding sites. Biochim. Biophys. Acta 1678, 111–125 (2004). · DOI
  19. Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nature Rev. Mol. Cell Biol. 6, 56–68 (2005). · DOI · Paper page
  20. Schaller, M. D. et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14, 1680–1688 (1994).
  21. Calalb, M. B., Polte, T. R. & Hanks, S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954–963 (1995). · DOI · Paper page
  22. Calalb, M. B., Zhang, X., Polte, T. R. & Hanks, S. K. Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem. Biophys. Res. Commun. 228, 662–668 (1996). · DOI
  23. Schlaepfer, D. D. & Hunter, T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 16, 5623–5633 (1996). · DOI · Paper page
  24. Grisaru-Granovsky, S. et al. Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int. J. Cancer 113, 372–378 (2004). · DOI
  25. Aronsohn, M. S., Brown, H. M., Hauptman, G. & Kornberg, L. J. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113, 1944–1948 (2003). · DOI
  26. Moon, H. S., Park, W. I., Choi, E. A., Chung, H. W. & Kim, S. C. The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas. Int. J. Gynecol. Cancer 13, 640–646 (2003). · DOI
  27. Brunton, V. G. et al. Identification of Src-specific phosphorylation site on FAK: dissection of the role of Src SH2 and catalytic functions and their consequences for tumour cell behaviour. Cancer Res. 65, 1335–1342 (2005). · DOI
  28. Sieg, D. J. et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nature Cell Biol. 2, 249–256 (2000). Highlights the underlying complexities of the role of FAK in mediating cellular signalling processes. Using reconstitution experiments in Fak−/− cells, the authors demonstrate that FAK links growth-factor receptors to integrin-controlled cell motility. However FAK is likely to have the role of adaptor or scaffold as its kinase activity might be dispensable for this role. · DOI · Paper page
  29. Matkowskyj, K. A. et al. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. J. Histochem. Cytochem. 51, 1041–1048 (2003). · DOI
  30. Avizienyte, E. et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nature Cell Biol. 4, 632–638 (2002). Demonstrated a requirement for SRC-mediated phosphorylation of FAK in the deregulation of E-cadherin-based cell–cell junctions in colon cancer cells. This paper linked integrin-induced signals to adhesion changes at cell junctions and provides evidence that FAK signalling could be important for the disassembly of cell–cell junctions that is associated with the epithelial–mesenchymal transition, and therefore perhaps invasion. · DOI · Paper page
  31. Eliceiri, B. P. et al. Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signalling. J. Cell Biol. 157, 149–160 (2002). · DOI · Paper page
  32. Chen, H. C., Chan, P. C., Tang, M. J., Cheng, C. H. & Chang, T. J. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J. Biol. Chem. 273, 25777–25782 (1998). · DOI
  33. Nakamura, K., Yano, H., Schaefer, E. & Sabe, H. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene 20, 2626–2635 (2001). · DOI
  34. Lim, Y. et al. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J. Biol. Chem. 279, 29060–29065 (2004). · DOI
  35. Parsons, J. T., Martin, K. H., Slack, J. K., Taylor, J. M. & Weed, S. A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19, 5606–5613 (2000). · DOI · Paper page
  36. Hsia, D. A. et al. Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160, 753–767 (2003). Demonstrates that FAK regulates both cell motility and invasion by distinct signalling pathways. Whereas v-Src expression in Fak−/− fibroblasts was sufficient to restore migration defects, FAK re-expression and the formation of a FAK–SRC–CAS–DOCK180 complex was necessary to promote invasion. · DOI
  37. Richardson, A. & Parsons, T. A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK. Nature 380, 538–540 (1996). · DOI · Paper page
  38. Webb, D. J. et al. FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nature Cell Biol. 6, 154–161 (2004). · DOI · Paper page
  39. Carragher, N. O., Westhoff, M. A., Fincham, V. J., Schaller, M. D. & Frame, M. C. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr. Biol. 13, 1442–1450 (2003). · DOI
  40. Ilic, D. et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539–544 (1995). · DOI · Paper page
  41. Ren, X. D. et al. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J. Cell Sci. 113, 3673–3678 (2000). · DOI · Paper page
  42. Franco, S., Perrin, B. & Huttenlocher, A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp. Cell Res. 299, 179–187 (2004). · DOI
  43. Carragher, N. O., Levkau, B., Ross, R. & Raines, E. W. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125FAK, paxillin, and talin. J. Cell Biol. 147, 619–630 (1999). · DOI · Paper page
  44. Carragher, N. O., Fincham, V. J., Riley, D. & Frame, M. C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 276, 4270–4275 (2001). · DOI
  45. Franco, S. J. et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nature Cell Biol. 6, 977–983 (2004). · DOI · Paper page
  46. Westhoff, M. A., Serrels, B., Fincham, V. J., Frame, M. C. & Carragher, N. O. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signalling. Mol. Cell. Biol. 24, 8113–8133 (2004). · DOI · Paper page
  47. Sebolt-Leopold, J. S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19, 6594–6599 (2000). · DOI · Paper page
  48. Mamoune, A. et al. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signalling. Exp. Cell Res. 299, 91–100 (2004). · DOI
  49. Braun, C. et al. Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int. J. Cancer 84, 6–9 (1999). · DOI
  50. Frame, M. C. Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 1602, 114–130 (2002).
  51. McLean, G. W., Avizienyte, E. & Frame, M. C. Focal adhesion kinase as a potential target in oncology. Expert Opin. Pharmacother. 4, 227–234 (2003). · DOI
  52. Almeida, E. A. et al. Matrix survival signalling: from fibronectin via focal adhesion kinase to c-Jun NH2-terminal kinase. J. Cell Biol. 149, 741–754 (2000). · DOI
  53. Huang, C., Rajfur, Z., Borchers, C., Schaller, M. D. & Jacobson, K. JNK phosphorylates paxillin and regulates cell migration. Nature 424, 219–223 (2003). · DOI · Paper page
  54. Subauste, M. C. et al. Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165, 371–381 (2004). · DOI · Paper page
  55. Schaller, M. D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 1–21 (2001). · DOI · Paper page
  56. Cary, L. A., Han, D. C., Polte, T. R., Hanks, S. K. & Guan, J. L. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140, 211–221 (1998). · DOI
  57. Sieg, D. J., Hauck, C. R. & Schlaepfer, D. D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112, 2677–2691 (1999). · DOI · Paper page
  58. Haskell, H. et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumours in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin. Cancer Res. 9, 2157–2165 (2003).
  59. Ilic, D. et al. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J. Cell Sci. 117, 177–187 (2004). · DOI
  60. Chen, B. H., Tzen, J. T., Bresnick, A. R. & Chen, H. C. Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. J. Biol. Chem. 277, 33857–33863 (2002). · DOI
  61. Zhai, J. et al. Direct interaction of focal adhesion kinase with p190RhoGEF. J. Biol. Chem. 278, 24865–24873 (2003). · DOI
  62. Liu, Y., Loijens, J. C., Martin, K. H., Karginov, A. V. & Parsons, J. T. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol. Biol. Cell 13, 2147–2156 (2002). · DOI
  63. Hildebrand, J. D., Taylor, J. M. & Parsons, J. T. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol. Cell. Biol. 16, 3169–3178 (1996). · DOI · Paper page
  64. Parsons, J. T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116, 1409–1416 (2003). · DOI · Paper page
  65. Wu, X., Suetsugu, S., Cooper, L. A., Takenawa, T. & Guan, J. L. Focal adhesion kinase regulation of N-WASP subcellular localization and function. J. Biol. Chem. 279, 9565–9576 (2004). · DOI
  66. Hauck, C. R., Hsia, D. A., Ilic, D. & Schlaepfer, D. D. v-Src SH3-enhanced interaction with focal adhesion kinase at β1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem. 277, 12487–12490 (2002). · DOI
  67. Lu, Z., Jiang, G., Blume-Jensen, P. & Hunter, T. Epidermal growth factor-induced tumour cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21, 4016–4031 (2001). · DOI · Paper page
  68. Yamada, K. M., Pankov, R. & Cukierman, E. Dimensions and dynamics in integrin function. Braz. J. Med. Biol. Res. 36, 959–966 (2003). · DOI
  69. Ilic, D. et al. Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. Am. J. Pathol. 159, 93–108 (2001). Showed that FAK was phosphorylated on Y397 during cytotrophoblast invasion of surrounding ECM. Knocking down FAK expression suppressed cytotrophoblast invasion, showing that FAK signalling, and autophosphorylation in particular, is also associated with normal invasive processes. · DOI
  70. Moissoglu, K. & Gelman, I. H. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J. Biol. Chem. 278, 47946–47959 (2003). · DOI
  71. Zhang, Y. et al. A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem. Biophys. Res. Commun. 290, 1123–1127 (2002). · DOI
  72. Shibata, K. et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58, 900–903 (1998).
  73. Wolf, K. et al. Compensation mechanism in tumour cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267–277 (2003). · DOI · Paper page
  74. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol. 5, 711–719 (2003). · DOI · Paper page
  75. Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Rev. Cancer 3, 362–374 (2003). · DOI · Paper page
  76. Friedl, P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16, 14–23 (2004). · DOI · Paper page
  77. Yano, H. et al. Roles played by a subset of integrin signalling molecules in cadherin-based cell–cell adhesion. J. Cell Biol. 166, 283–295 (2004). · DOI
  78. Wang, H., Radjendirane, V., Wary, K. K. & Chakrabarty, S. Transforming growth factor β regulates cell–cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23, 5558–5561 (2004). · DOI
  79. Quadri, S. K., Bhattacharjee, M., Parthasarathi, K., Tanita, T. & Bhattacharya, J. Endothelial barrier strengthening by activation of focal adhesion kinase. J. Biol. Chem. 278, 13342–13349 (2003). · DOI
  80. Frisch, S. M., Vuori, K., Ruoslahti, E. & Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793–799 (1996). · DOI · Paper page
  81. Chan, P. C. et al. Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin–Darby canine kidney cells. J. Biol. Chem. 274, 26901–26906 (1999). · DOI
  82. Sonoda, Y. et al. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275, 16309–16315 (2000). · DOI · Paper page
  83. Sakurai, S. et al. Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G. Biochem. Biophys. Res. Commun. 293, 174–181 (2002). · DOI
  84. Liu, X. J. et al. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J. Gastroenterol. 8, 734–738 (2002). · DOI
  85. Hungerford, J. E., Compton, M. T., Matter, M. L., Hoffstrom, B. G. & Otey, C. A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol. 135, 1383–1390 (1996). · DOI · Paper page
  86. Xu, L. H. et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumour cells. Cell Growth Differ. 7, 413–418 (1996).
  87. van de Water, B., Houtepen, F., Huigsloot, M. & Tijdens, I. B. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. J. Biol. Chem. 276, 36183–36193 (2001). · DOI
  88. Jones, G., Machado, J. Jr, Tolnay, M. & Merlo, A. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumours which highly express focal adhesion kinase (FAK). Cancer Res. 61, 5688–5691 (2001).
  89. Golubovskaya, V. et al. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J. Biol. Chem. 277, 38978–38987 (2002). · DOI
  90. Golubovskaya, V. M. et al. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 1, 755–764 (2003).
  91. Xu, L. H. et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signalling pathways. J. Biol. Chem. 275, 30597–30604 (2000). · DOI
  92. Beviglia, L. et al. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem. J. 373, 201–210 (2003). · DOI
  93. Kurenova, E. et al. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol. Cell. Biol. 24, 4361–4371 (2004). Provides new mechanistic insight into the role of FAK as a suppressor of apoptosis by providing evidence of a link between FAK and the death-receptor complex. FAK is shown to bind to RIP (a pro-apoptotic member of the death-receptor complex) and inhibit its function, so providing a possible link between the overexpression of FAK found in many tumours and aberrantly regulated survival signalling. · DOI
  94. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W. & Whang, E. E. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135, 555–562 (2004). Highlights the possible therapeutic benefit of FAK gene silencing. In pancreatic cell lines FAK RNAi resulted in death of anoikis-resistant resistant cell lines, and in suppression of metastasis. · DOI
  95. Duxbury, M. S. et al. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311, 786–792 (2003). · DOI
  96. Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med. 5, 662–668 (1999). · DOI · Paper page
  97. Aguirre Ghiso, J. A. Inhibition of FAK signalling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21, 2513–2524 (2002). · DOI
  98. Hecker, T. P., Grammer, J. R., Gillespie, G. Y., Stewart, J. Jr. & Gladson, C. L. Focal adhesion kinase enhances signalling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumour biopsy samples. Cancer Res. 62, 2699–26707 (2002).
  99. Hecker, T. P., Ding, Q., Rege, T. A., Hanks, S. K. & Gladson, C. L. Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells. Oncogene 23, 3962–3971 (2004). · DOI
  100. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78–80 (1986). · DOI · Paper page
  101. McLean, G. W. et al. Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res. 61, 8385–8389 (2001).
  102. Indra, A. K. et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27, 4324–4327 (1999). · DOI · Paper page
  103. McLean, G. W. et al. Specific deletion of focal adhesion kinase suppresses tumour formation and blocks malignant progression. Genes Dev. 18, 2998–3003 (2004). Using a mouse skin carcinogenesis model and skin-specific conditional FAK deletion, this report provides the first in vivo evidence for a causative role for FAK during tumour progression. Cre –LOX driven FAK ablation both reduced benign papilloma formation and blocked progression to malignant squamous-cell carcinoma, an effect that was shown to be linked to the anti-apoptotic function of FAK. · DOI
  104. Hanks, S. K., Ryzhova, L., Shin, N. Y. & Brabek, J. Focal adhesion kinase signalling activities and their implications in the control of cell survival and motility. Front Biosci. 8, 982–996 (2003). · DOI · Paper page
  105. Duan, W. R. et al. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 199, 221–228 (2003). · DOI · Paper page
  106. Marshman, E., Ottewell, P. D., Potten, C. S. & Watson, A. J. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J. Pathol. 195, 285–292 (2001). · DOI
  107. Argyris, T. S. Tumour promotion by abrasion induced epidermal hyperplasia in the skin of mice. J. Invest. Dermatol. 75, 360–362 (1980). · DOI
  108. Miyazaki, T. et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 89, 140–145 (2003). · DOI
  109. Cary, L. A., Chang, J. F. & Guan, J. L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 109, 1787–1794 (1996). · DOI · Paper page
  110. Sawyer, T., Boyce, B., Dalgarno, D. & Iuliucci, J. Src inhibitors: genomics to therapeutics. Expert Opin. Investig. Drugs 10, 1327–1344 (2001). · DOI
  111. Gay, B. et al. Selective GRB2 SH2 inhibitors as anti-Ras therapy. Int. J. Cancer 83, 235–241 (1999). · DOI
  112. Katz, B. Z. et al. Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases. J. Biol. Chem. 278, 29115–29120 (2003). · DOI
  113. Avizienyte, E., Fincham, V. J., Brunton, V. G. & Frame, M. C. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial–mesenchymal transition. Mol. Biol. Cell 15, 2794–2803 (2004). · DOI
  114. Chikumi, H., Fukuhara, S. & Gutkind, J. S. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase. J. Biol. Chem. 277, 12463–12473 (2002). · DOI
  115. Hauck, C. R., Hsia, D. A., Puente, X. S., Cheresh, D. A. & Schlaepfer, D. D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21, 6289–6302 (2002). · DOI
  116. van Nimwegen, M. J., Verkoeijen, S., van Buren, L., Burg, D. & van de Water, B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 65, 4698–4706 (2005). · DOI

Cited by

See all 1,039

Metadata

Authors
McLean, G. W., Carragher, N. O., Avizienyte, E., Evans, J., Brunton, V. G., & Frame, M. C.
Venue
Nature Reviews Cancer
Publisher
Springer Science and Business Media LLC
Published
2005-07-01
Volume
5
Issue
7
Pages
505-515
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
DOI
10.1038/nrc1647
OpenAlex
W2310034942
Cited by
1,039
References
6
FWCI
2.51
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of focal-adhesion kinase in cancer — a new therapeutic opportunity. https://app.cochat.ai/papers/10.1038/nrc1647
The paper
McLean, G. W., Carragher, N. O., Avizienyte, E., Evans, J., Brunton, V. G., & Frame, M. C. (2005). The role of focal-adhesion kinase in cancer — a new therapeutic opportunity. Nature Reviews Cancer. https://doi.org/10.1038/nrc1647

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.